Víctor A. López

2.7k citations

39 papers · 1.9k indexed · 1 hit paper · h-index 18

Cardiology and Cardiovascular Medicine top 2%
Radiology, Nuclear Medicine and Imaging top 2%
Surgery top 10%
Pulmonary and Respiratory Medicine top 10%
Endocrinology, Diabetes and Metabolism top 5%

Co-authors: Nathan D. Wong Arnold F. Jacobson Gregory S. Thomas Fred Weiland Harish Chandna Roxy Senior Denis Agostini Manuel D. Cerqueira
Topics: Blood Pressure and Hypertension Studies (7 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers)Lipoproteins and Cardiovascular Health (5 papers)
Cited by: Cardiology and Cardiovascular Medicine Radiology, Nuclear Medicine and Imaging Endocrinology, Diabetes and Metabolism
Journals: CirculationSHILAP Revista de lepidopterologíaJournal of the American College of Cardiology
Partner nations: United States Mexico United Kingdom

In The Last Decade

Víctor A. López

37 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure

2010 585 citations Arnold F. Jacobson, Roxy Senior et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Víctor A. López

Since Specialization

Citations

This map shows the geographic impact of Víctor A. López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor A. López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor A. López more than expected).

Fields of papers citing papers by Víctor A. López

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor A. López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor A. López. The network helps show where Víctor A. López may publish in the future.

Co-authorship network of co-authors of Víctor A. López

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor A. López. A scholar is included among the top collaborators of Víctor A. López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor A. López. Víctor A. López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients 2024 ·Clinical and Experimental Rheumatology ·Yusuf Yazıcı,J. Tambiah,Christopher J. Swearingen,Víctor A. López,Sarah J. Kennedy,Mark Fineman,İsmail Şimşek,(unknown),Timothy E. McAlindon	2
2	Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study 2023 ·Rheumatology and Therapy ·Mark Fineman,Timothy E. McAlindon,Christian Lattermann,Christopher J. Swearingen,Sarah J. Kennedy,Víctor A. López,İsmail Şimşek,J. Tambiah,Yusuf Yazıcı	3
3	Ablative and Immunostimulatory Effects of Histotripsy Ablation in a Murine Osteosarcoma Model 2023 ·Biomedicines ·(unknown),Khan Mohammad Imran,(unknown),Jessica M. Gannon,(unknown),Alex Simon,Víctor A. López,Sheryl Coutermarsh‐Ott,Eli Vlaisavljevich,Irving C. Allen,Joanne Tuohy	8
4	<p>INTELIGENCIA EMOCIONAL PERCIBIDA EN UNA POBLACIÓN DE UNIVERSITARIOS</p> 2022 ·(unknown),(unknown),(unknown),Víctor A. López	1
5	INFLUENCIA DE MEMORIA Y ATENCIÓN EN LA CALIDAD DE VIDA DE LA POBLACIÓN GERIÁTRICA 2021 ·(unknown),Víctor A. López	0
6	Machine Learning in Acute Ischemic Stroke Neuroimaging 2018 ·Frontiers in Neurology ·Haris Kamal,Víctor A. López,Sunil A. Sheth	74
7	Intervenciones para promover estilos de vida saludables y su efecto en las variables psicológicas en sobrevivientes de cáncer de mama: revisión sistemática 2018 ·Nutrición Hospitalaria ·Víctor A. López,(unknown),Graciela Caire‐Juvera	15
8	Tres casos de gammapatía monoclonal de significado renal postrasplante renal: nefropatía c3 de novo 2018 ·Nefrología ·Núria Serra,Carme Facundo,Cristina Canal,Yolanda Arce,(unknown),Anna Vila,(unknown),Irene Silva,Víctor A. López,Silvia Benito,José Ballarín,Lluís Guirado	3
9	GSK2878175, a pan‐genotypic non‐nucleoside NS5B polymerase inhibitor, in healthy and treatment‐naïve chronic hepatitis C subjects 2017 ·Journal of Viral Hepatitis ·Stephen D. Gardner,Jae Bum Kim,(unknown),Víctor A. López,Robert Hamatake,(unknown),Sally Edwards,(unknown),Étienne Dumont,(unknown),Zhi Hong,Melanie Paff	10
10	Abstract 10053: Progression of Coronary Calcium and Incident Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA) 2011 ·Circulation ·Matthew J. Budoff,Víctor A. López,Khurram Nasir,Roger S. Blumenthal,Robert Detrano,Richard A. Kronmal,Diane E. Bild,Alan D. Guerci,Kiang Liu,Steven Shea,(unknown),Wendy S. Post,Joao A Lima,Alain G. Bertoni,Nathan D. Wong	1
11	Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality 2010 ·European Respiratory Journal ·(unknown),Hoa Le,Brian T. Lee,Víctor A. López,Nathan D. Wong	70
12	Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failurebreakdown → 2010 ·Journal of the American College of Cardiology ·Arnold F. Jacobson,Roxy Senior,Manuel D. Cerqueira,Nathan D. Wong,Gregory S. Thomas,Víctor A. López,Denis Agostini,Fred Weiland,Harish Chandna,Jagat Narula	585
13	Prevalence of Diabetes and Cardiovascular Risk Factors Among California Native American Adults Compared to Other Ethnicities: The 2005 California Health Interview Survey 2010 ·Metabolic Syndrome and Related Disorders ·(unknown),Alejandro Pérez,Víctor A. López,Nathan D. Wong	13
14	Use of the UKPDS Outcomes Model to predict all-cause mortality in U.S. adults with type 2 diabetes mellitus: Comparison of predicted versus observed mortality 2010 ·Diabetes Research and Clinical Practice ·(unknown),Charles M. Alexander,Panagiotis Mavros,Víctor A. López,Shaista Malik,Hemant Phatak,Nathan D. Wong	16
15	Cardiovascular comorbidities and blood pressure control in stroke survivors 2009 ·Journal of Hypertension ·(unknown),Alejandro Pérez,Víctor A. López,Nathan D. Wong,Stanley S. Franklin	35
16	Cardiovascular risk factors in the urban Mexican population: The FRIMEX study 2007 ·Public Health ·Eduardo Meaney,Agustín Lara‐Esqueda,Guillermo Ceballos,Juan Asbún,(unknown),(unknown),Víctor A. López,Alejandra Meaney,(unknown),Oscar J Velázquez-Monroy,Roberto Tapia‐Conyer	30
17	Coronary Heart Disease Events Preventable by Control of Blood Pressure and Lipids in US Adults With Hypertension 2007 ·Journal of Clinical Hypertension ·Víctor A. López,Stanley S. Franklin,Simon Tang,Nathan D. Wong	18
18	Prevalence, Treatment, and Control of Combined Hypertension and Hypercholesterolemia in the United States 2006 ·The American Journal of Cardiology ·Nathan D. Wong,Víctor A. López,Simon Tang,G. Rhys Williams	127
19	Undertreatment of cardiovascular risk factors among persons with diabetes in the United States 2006 ·Diabetes Research and Clinical Practice ·Shaista Malik,Víctor A. López,Roland Chen,(unknown),Nathan D. Wong	69
20	Tabaco y enfermedad cardiovascular 2004 ·Adicciones ·(unknown),(unknown),(unknown),Víctor A. López	4

About Víctor A. López

Víctor A. López is a scholar working on Family Practice, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (987 citations), Radiology, Nuclear Medicine and Imaging (633 citations) and Endocrinology, Diabetes and Metabolism (217 citations). Víctor A. López has collaborated with scholars based in United States, Mexico and United Kingdom. Frequent co-authors include Nathan D. Wong, Arnold F. Jacobson, Gregory S. Thomas, Fred Weiland, Harish Chandna, Roxy Senior, Denis Agostini, Manuel D. Cerqueira, Jagat Narula and Stanley S. Franklin. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact